0 followers
Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.
James McCullough
Kura Oncology
20 followers
SpringWorks Therapeutics
6 followers
Biofourmis
6 followers
REVOLUTION Medicines
5 followers
C4 Therapeutics
5 followers
Immunovant
5 followers
Tectonic Therapeutic
4 followers
Stemline Therapeutics
3 followers
Dyne Therapeutics
3 followers
Precigen
3 followers
Arcturus Therapeutics
2 followers
Explore companies